EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C18H30O7 |
| Net Charge | 0 |
| Average Mass | 358.431 |
| Monoisotopic Mass | 358.19915 |
| SMILES | CC(O)CCC[C@H](O)/C=C/[C@@H]1[C@@H](CC(=O)CCC(=O)O)[C@@H](O)C[C@H]1O |
| InChI | InChI=1S/C18H30O7/c1-11(19)3-2-4-12(20)5-7-14-15(17(23)10-16(14)22)9-13(21)6-8-18(24)25/h5,7,11-12,14-17,19-20,22-23H,2-4,6,8-10H2,1H3,(H,24,25)/b7-5+/t11?,12-,14+,15+,16+,17-/m0/s1 |
| InChIKey | CCDLUYBTWPYEFY-VKOLDSHFSA-N |
| Roles Classification |
|---|
| Chemical Role: | Bronsted acid A molecular entity capable of donating a hydron to an acceptor (Brønsted base). |
| Biological Role: | metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| 19-hydroxy-2,3-dinor-6-oxoprostaglandin F1α (CHEBI:73951) has functional parent 2,3-dinor-6-oxoprostaglandin F1α (CHEBI:73944) |
| 19-hydroxy-2,3-dinor-6-oxoprostaglandin F1α (CHEBI:73951) has role metabolite (CHEBI:25212) |
| 19-hydroxy-2,3-dinor-6-oxoprostaglandin F1α (CHEBI:73951) is a 4-oxo monocarboxylic acid (CHEBI:35950) |
| 19-hydroxy-2,3-dinor-6-oxoprostaglandin F1α (CHEBI:73951) is a prostanoid (CHEBI:26347) |
| 19-hydroxy-2,3-dinor-6-oxoprostaglandin F1α (CHEBI:73951) is a secondary alcohol (CHEBI:35681) |
| IUPAC Names |
|---|
| (13E,15S)-9α,11α,15,19-tetrahydroxy-2,3-dinor-6-oxoprost-13-en-1-oic acid |
| 5-{(1R,2R,3R,5S)-2-[(1E,3S)-3,7-dihydroxyoct-1-en-1-yl]-3,5-dihydroxycyclopentyl}-4-oxopentanoic acid |
| Synonyms | Source |
|---|---|
| 19-hydroxy-6-keto-2,3-dinor-prostaglandin F1α | ChEBI |
| 2,3-dinor-6-oxo-19-hydroxy-prostaglandin F1α | ChEBI |
| 19-hydroxy-2,3-dinor-6-keto-prostaglandin F1α | ChEBI |
| 19-hydroxy-2,3-dinor-6-oxo-prostaglandin F1α | ChEBI |
| 19-hydroxy-2,3-dinor-6-oxo-PGF1α | ChEBI |
| 2,3-dinor-6-keto-19-hydroxy-prostaglandin F1α | ChEBI |